|
欢迎您加入月均活跃用户100万＋的科研社区！
如您有任何建议，请；有合作推广需求，请点此洽谈。 
|
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 外科/肿瘤/心血管/神经/胃肠43本刊征稿，附文章处理费折扣！ | 热 SCI论文AI润色+人工QC服务 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | ImmunoTargets and Therapy （此期刊被最新的JCR期刊ESCI收录） LetPub评分 4.3
51人评分
我要评分
声誉 4.8 影响力 3.4 速度 7.1 | |||||||||||||||||||||
| 期刊ISSN | 2253-1556 | 
蝌蝌APP，让您与同行交流更轻松
 立即下载 | ||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 4.4 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | - | |||||||||||||||||||||
| 2024-2025自引率 | 0.00%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 7.9 | |||||||||||||||||||||
| JCI期刊引文指标 | 0.72 | |||||||||||||||||||||
| h-index | 暂无h-index数据 | |||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | https://www.dovepress.com/immunotargets-and-therapy-journal | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | ||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | The Regulatory Network of Transcription Factors in Macrophage Polarization Author: Liu, Jie; Wang, Mengran; Zhao, Yong Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 555-575. DOI: 10.2147/ITT.S494550 Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal Carcinoma Author: Xie, Honghui; Zhang, Lin; Chen, Lizhi; Zhou, Wenchao; Zhang, Lijuan; Su, Yong; Li, Bocheng; Ding, Peng; Xiao, Yun; Lu, Tianzhu; Gong, Xiaochang; Li, Jingao Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 577-587. DOI: 10.2147/ITT.S516853 How to Choose Treatment Regimens for Idiopathic Membranous Nephropathy Patients with PLA2R-Negative: A Single-Center Retrospective Cohort Study Author: Zhou, Zijian; Zou, Yijing; Ke, Ben; Shen, Wen Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 515-522. DOI: 10.2147/ITT.S512451 Lysyl Oxidase-Like 1 (LOXL1) Up-Regulation in Chondrocytes Promotes M1 Macrophage Activation in Osteoarthritis via NF-κB and STAT3 Signaling Author: Jiang, Yuyun; Wang, Shang; Zhu, Wei; Liu, Xi; Yang, Yanwei; Huo, Liyue; Ye, Jixian; Ma, Yongbin; Zhou, Yuepeng; Yang, Zhe; Mao, Jiahui; Wang, Xuefeng Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 259-278. DOI: 10.2147/ITT.S512768 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足ImmunoTargets and Therapy的语言要求，还能让ImmunoTargets and Therapy编辑和审稿人得到更好的审稿体验，让稿件最大限度地被ImmunoTargets and Therapy编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD3300; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：immunology、immune system、immune-based therapy 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
| 通讯方式 | ||||||||||||||||||||||
| 出版商 | Dove Medical Press | |||||||||||||||||||||
| 涉及的研究方向 | IMMUNOLOGY- | |||||||||||||||||||||
| 出版国家或地区 | United Kingdom | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 55点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 98.65% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 74.55% | |||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：2区
| |||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中国科学院期刊分区 （ 2025年3月最新升级版） | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||
| 中国科学院期刊分区 （ 2023年12月升级版） | （没有被2023年的JCR升级版收录，仅供参考） | |||||||||||||||||||||
| 中国科学院期刊分区 （ 2022年12月旧的升级版） | （没有被旧的JCR升级版收录，仅供参考） | |||||||||||||||||||||
| SCI期刊收录coverage | Emerging Sources Citation Index (ESCI) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2253-1556%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 16 Weeks | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ USD3300; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在ImmunoTargets and Therapy顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | The Regulatory Network of Transcription Factors in Macrophage Polarization Author: Liu, Jie; Wang, Mengran; Zhao, Yong Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 555-575. DOI: 10.2147/ITT.S494550 PubMed DOI |
| 2. | Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal Carcinoma Author: Xie, Honghui; Zhang, Lin; Chen, Lizhi; Zhou, Wenchao; Zhang, Lijuan; Su, Yong; Li, Bocheng; Ding, Peng; Xiao, Yun; Lu, Tianzhu; Gong, Xiaochang; Li, Jingao Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 577-587. DOI: 10.2147/ITT.S516853 PubMed DOI |
| 3. | How to Choose Treatment Regimens for Idiopathic Membranous Nephropathy Patients with PLA2R-Negative: A Single-Center Retrospective Cohort Study Author: Zhou, Zijian; Zou, Yijing; Ke, Ben; Shen, Wen Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 515-522. DOI: 10.2147/ITT.S512451 PubMed DOI |
| 4. | Lysyl Oxidase-Like 1 (LOXL1) Up-Regulation in Chondrocytes Promotes M1 Macrophage Activation in Osteoarthritis via NF-κB and STAT3 Signaling Author: Jiang, Yuyun; Wang, Shang; Zhu, Wei; Liu, Xi; Yang, Yanwei; Huo, Liyue; Ye, Jixian; Ma, Yongbin; Zhou, Yuepeng; Yang, Zhe; Mao, Jiahui; Wang, Xuefeng Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 259-278. DOI: 10.2147/ITT.S512768 PubMed DOI |
| 5. | Causal Association Between Circulating Inflammatory Proteins and Autoimmune Liver Disease: a Bidirectional Two-Sample Mendelian Randomization Study Author: Leng, Lina; Li, Ying; Xu, Tao; Shen, Jingfang; Li, Lianju; Li, Xiaoli Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 279-289. DOI: 10.2147/ITT.S508140 PubMed DOI |
| 6. | Tumor Immunotherapy Targeting B7-H3: From Mechanisms to Clinical Applications Author: Guo, Yining; Wang, Xudong; Zhang, Chen; Chen, Weiwu; Fu, Yutian; Yu, Yanlan; Chen, Yicheng; Shao, Tiejuan; Zhang, Jie; Ding, Guoqing Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 291-320. DOI: 10.2147/ITT.S507522 PubMed DOI |
| 7. | Recombinant Antithrombin Alleviated Pulmonary Injury and Inflammation in LPS-Induced ARDS by Inhibiting IL17a/NF-κB Signaling Author: Yang, Chen; Fu, Cong; Wang, Mengxue; Zheng, Junbo; Gao, Yang; Zhu, Huiting; Li, Haoxuan; Li, Dongxu; Guo, Lichen; Yu, Bing; Dai, Qingqing Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 433-449. DOI: 10.2147/ITT.S502925 PubMed DOI |
| 8. | Integration of scRNA-Seq and Bulk RNA-Seq Identifies Circadian Rhythm Disruption-Related Genes Associated with Prognosis and Drug Resistance in Colorectal Cancer Patients Author: Tao, Yong; Li, Jun; Pan, Jianhui; Wang, Qing; Ke, Ru Wei; Yuan, Danping; Wu, Hongbiao; Cao, Yuepeng; Zhao, Lei Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 475-489. DOI: 10.2147/ITT.S499806 PubMed DOI |
| 9. | Comprehensive Analyses of Single-Cell and Bulk RNA Sequencing Data From M2 Macrophages to Elucidate the Immune Prognostic Signature in Patients with Gastric Cancer Peritoneal Metastasis Author: Tang, Qiao; Tang, Liang; Wang, Xiaofeng; Zhang, Yongxin; Liu, Wenwei; Yang, Ting; Wu, Yuxin; Ma, Yuanchen; Lei, Tianxiang; Song, Wu Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 383-402. DOI: 10.2147/ITT.S506143 PubMed DOI |
| 10. | A Case Series of Anti-Metabotropic Glutamate Receptor 2 Antibody-Related Diseases with Distinct Neurological Involvement Author: Zhang, Zhanwei; Deng, Xiaolu; Guo, Dandan; Zhao, Jie; Li, Jian; He, Fang; Yang, Lifen; Peng, Jing Journal: IMMUNOTARGETS AND THERAPY. 2025; Vol. 14, Issue , pp. 465-474. DOI: 10.2147/ITT.S514617 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| Springer发布AI审稿筛查工具：科研人怎么看？加入讨论 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共0条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
